- Stocks
- Pharma & Healthcare
- Shelter Pharma
Shelter Pharma share price
NSE: SHELTERPharma & HealthcareDrug Manufacturers - Specialty & Generic
Shelter Pharma at a glance
With a market capitalisation of ₹46 Cr, it ranks 3125th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.
Its return on equity was 11.8% in FY26. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹28 Cr (−4.9% year on year) and net profit ₹0 Cr (−90.1%), on a consolidated basis. Promoters held 44.38% of the company as of 14 May 2026.
Key numbers
- Market cap
- ₹46 CrRank 3125 on NSE
- Price to book
- 0.58×FY26
- EPS (TTM)
- ₹0.38to Q1 FY27
- ROE
- 11.8%FY26
- ROCE
- 16.0%FY26
- Debt to equity
- 0.01FY26
- Net profit margin
- 12.3%FY26
- Book value / share
- ₹46.13FY26
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
Shelter Pharma quarterly results
| Quarter | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹34 Cr | ₹32 Cr | ₹34 Cr | ₹30 Cr | ₹35 Cr | ₹31 Cr | ₹34 Cr | ₹28 Cr |
| Revenue YoY | +23.1% | +24.6% | +4.6% | +2.0% | +1.8% | −4.5% | +0.5% | −4.9% |
| Net profit | ₹0 Cr | ₹0 Cr | −₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | −₹1 Cr | ₹0 Cr |
| Net profit YoY | +145.5% | −100.0% | −353.8% | +170.0% | +296.3% | — | — | −90.1% |
| Net margin | 0.8% | 0.0% | −1.0% | 2.7% | 3.1% | 2.4% | −2.6% | 0.3% |
| EPS | ₹0.11 | — | −₹0.13 | ₹0.31 | ₹0.40 | ₹0.29 | −₹0.34 | ₹0.03 |
Shelter Pharma financials
| Item | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹40 Cr | ₹51 Cr | — |
| Operating profit | ₹8 Cr | ₹10 Cr | — |
| Net profit | ₹6 Cr | ₹7 Cr | — |
| EPS (₹) | ₹5.36 | ₹6.26 | — |
| Cash from operations | −₹2 Cr | ₹5 Cr | — |
| Total debt | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| Shareholders' equity | ₹36 Cr | ₹43 Cr | ₹77 Cr |
Shelter Pharma shareholding pattern
| Holder | 16 Nov 2025 | 18 Nov 2025 | 8 Mar 2026 | 31 Mar 2026 | 2 May 2026 | 14 May 2026 |
|---|---|---|---|---|---|---|
| Promoters | 44.70% | 47.19% | 44.41% | 44.99% | 44.68% | 44.38% |
| Non-institutions | 55.30% | 52.81% | 55.59% | 55.01% | 55.32% | 55.62% |
Shelter Pharma vs peers
The listed Pharma & Healthcare companies nearest to Shelter Pharma by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| BIOFILCHEMBiofil Chemicals & Pharmaceuticals | ₹30.00 | +2.15% | −27.3% | ₹49 Cr | 17.5 | — |
| SHANMUGAShanmuga Hospit | — | — | — | ₹48 Cr | — | — |
| MANGALAMMangalam Drugs And Organics | ₹29.66 | −3.07% | −58.5% | ₹47 Cr | — | — |
| AMKAYAmkay Products | — | — | — | ₹46 Cr | — | — |
| SHELTERShelter Pharma | — | — | — | ₹46 Cr | — | — |
| VISTAPHVista Pharma | — | — | — | ₹45 Cr | — | — |
| KMSMEDIKMS Medisurgi | — | — | — | ₹43 Cr | — | — |
Ask anything about Shelter Pharma
Pivot answers on the live chart with evidence you can check, and tests strategies against SHELTER's own history. Try: “Why has SHELTER moved over the last three months?” · “Backtest a 50-day moving-average crossover on SHELTER over five years” · “Compare SHELTER with BIOFILCHEM on margins and valuation”
Frequently asked questions about Shelter Pharma
What is the market cap of Shelter Pharma?
Shelter Pharma's market capitalisation is ₹46 Cr (₹46 Cr) at the 22 Oct 2026 close, ranking 3125th among the NSE companies Pivot tracks.
What is the ROE and ROCE of Shelter Pharma?
Return on equity was 11.8% in FY26 and return on capital employed was 16.0% in FY26 (standalone figures).
Is Shelter Pharma a debt-free company?
Shelter Pharma is close to debt-free: its debt-to-equity ratio was 0.01 in FY26.
What were Shelter Pharma's latest quarterly results?
For Q1 FY27 (quarter ended 30 Jun 2026), Shelter Pharma reported revenue of ₹28 Cr, −4.9% year on year, and net profit of ₹0 Cr, −90.1% year on year.
What is the shareholding pattern of Shelter Pharma?
As of 14 May 2026: promoters 44.38%, non-institutions 55.62%.
Who are Shelter Pharma's competitors?
The listed Pharma & Healthcare companies closest to Shelter Pharma by market cap are Biofil Chemicals & Pharmaceuticals, Shanmuga Hospit, Mangalam Drugs And Organics, Amkay Products, Vista Pharma and KMS Medisurgi.
Is Shelter Pharma a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Shelter Pharma's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on SHELTER against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with S · all NSE stocks · this page as text